Allyson Kornfeld, MD
Obstetrics & Gynecology · Kansas City, MONPI 1194220160
Payments from drug & device makers
Across 48 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$315
- LSI Solutions Inc$163
- Organon$99
- Exeltis, USA Inc.$95
- Boston Scientific$86
- Exact Sciences$78
- plus $286 from 10 others
What the payments were for
- Food & beverage$1,121100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 18 | $315 |
| LSI Solutions Inc | 1 | $163 |
| Organon | 5 | $99 |
| Exeltis, USA Inc. | 5 | $95 |
| Boston Scientific | 1 | $86 |
| Exact Sciences | 3 | $78 |
| Coopersurgical, Inc. | 3 | $57 |
| AbbVie | 3 | $53 |
| Bayer | 2 | $37 |
| Tesaro, Inc. | 1 | $29 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Millicent US Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FORNISEE$163
How this compares
$1,121 in reported general payments places this provider in the 65th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 122 | $6,421 |
| Estradiol (Once Weekly)Estradiol | 11 | $1,292 |
| ProgesteroneProgesterone, Micronized | 29 | $901 |
| Clobetasol Propionate | 32 | $735 |
| ValacyclovirValacyclovir Hcl | 21 | $519 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $248 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $241 |
| Acyclovir | 16 | $210 |
| Metronidazole | 16 | $175 |
| Fluconazole | 33 | $135 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kansas City
- Amy CarterKansas City$49K
- Lori KramerKansas City$11K
- Allyssa KaysKansas City$7K
- Thomas ShultzSpringfield$1.1M
- Kent BransonCreve Coeur$576K
- Saji JacobSt. Louis$411K
- Becky LynnSaint Louis$231K
- Timothy HallIndependence$172K
- Craig McCoyMoberly$101K
- Andrew DavisSt. Louis$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.